Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Fulminant hepatic failure is characterized by the development of severe liver injury with impaired synthetic capacity and encephalopathy in patients with previous normal liver or at least well compensated liver disease. The etiology of fulminant hepatic failure refers to a wide variety of causes, of which toxin-induced or viral hepatitis are most common. In spite of specific therapeutic options in distinctive etiologies, orthotopic liver transplantation is the only therapy proven to improve patient survival in the majority of patients. The outcome is determined by the complications like severe coagulopathy, infections, renal impairment or increased intracranial pressure. The decision for transplantation depends on the possibility of spontaneous hepatic recovery, which may be estimated by several factors. The most important variables for predicting the need of transplantation in fulminant hepatic failure are the degree of encephalopathy, patients age and the underlying cause of liver failure.
OMICS Group
OMICS International is an integration of Open Access publications and worldwide International Scientific conferences. Its Open Access Initiative is committed to produce real and reliable contributions to the scientific community. OMICS Group is a pioneer and leading Scientific event organizer, which publishes around 400 peer reviewed open access journals in all aspects of science, health and technology. OMICS Group world class International scientific conferences organizer successfully coordinates 300 International conferences across the globe to accelerate the knowledge transfer through debates, round table discussions, poster presentations, workshops, symposia and exhibitions. OMICS conferences also provide the perfect platform to interact with peers from both industry and academia. OMICS Group Journals have over 3.5 million readers and the glory could be attributed to the committed editorial board containing over 30,000 editorial board members worldwide who ensure the quality of the articles remain unparalleled. Furthermore, OMICS Group has been associated with 1000 more International scientific associations.
Conference:
National Liver Conference 2014
ILCA 2014 - International Liver Cancer Association 8th Annual Conference
8th Australasian Viral Hepatitis Conference 2014
The Viral Hepatitis Congress 2014
XXIII Congress of the Latin American Association for the Study of the Liver
4th World Congress on Controversies in the Management of Viral Hepatitis (C-Hep 2015)
ILCA 2014: International Liver Cancer Association 8th Annual Conference
GI and Liver Association of the Americas (GALA) Montreal Conference
Frontiers in Pediatric Gastroenterology, Hepatology & Nutrition 2014
Gastroenterology, Hepatology, and Nutrition Update 2014
14th Annual Dartmouth Conference on Liver, Pancreas and Biliary Diseases: Interventions in Pancreatic and Biliary Disease
Mayo Clinic Gastroenterology & Hepatology 2015
50th The International Liver Congress
National symposiums and workshops:
49th annual meeting of the European Association for the Study of the Liver
Critical Care Medicine Symposium
Indonesian Association for the Study of the Liver
Mount Sinai Intensive Review in Gastroenterology & Hepatology
Intensive Review of Gastroenterology and Hepatology
XXIII Congress of the Latin-American Association for the Study of the Liver
European Association for the Study of the Liver (EASL) Special Conference: Optimal Management of Hepatitis B Virus Infection
8th Annual UCLA Liver Diseases Symposium
The Liver Meeting
3rd LA Viral Hepatitis and Co-infection Workshop 2014
10th Annual Liver Transplant Symposium
17th Annual Liver Disease Wrap-Up
The Global Viral Hepatitis Summit – 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)
Annual Scientific Congress of the Malaysian Society of Gastroenterology and Hepatology
Association & society:
Malaysian Society of Gastroenterology and Hepatology
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
European Association for the Study of the Liver (EASL)
Canadian liver foundation
GI and Liver Association of the Americas (GALA) San Francisco
American association of study of liver disease
Indonesian Association for the Study of the Liver
American liver foundation
British liver trust
Children’s liver disease foundation
Indian Association for Study of the Liver
Business value and company
In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did not see much progress, causing overall global sales to remain stagnant at $12.4 billion. Estimated sales in 2011 a projected $12 billion (excluding protease inhibitors). The market is expected to rise at a CAGR of 3.3% and reach nearly $14.2 billion by 2016.
Ambit Biosciences
ImClone Systems
Biovest Company
Smith, Kline & French
Medavir AB
Conatus Pharmaceuticals
Salix Pharmaceuticalsv Idenix Pharmaceuticals
Enanta Pharmaceuticals
Galectin Therapeutics
Abbott Laboratories
Endo Health Solutions
Forest Laboratories
Gilead Sciences
ACT Biotech Inc
Endo Health Solutions
Alnylam Pharmaceuticals
This page will be updated regularly.
This page was last updated on November 22, 2024
